| 2025 | 2024 | 2023 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 635,6 k € | — | — | — | |||||||||||
| Gross margin | 911,7 k € | -65.4% | 2,6 M € | -11.4% | 3,0 M € | +36.4% | 2,2 M € | +234.3% | 653,0 k € | +289.2% | 167,8 k € | +119.8% | 76,3 k € | -75.6% | 313,2 k € | +262.1% | -193,1 k € | +56.9% | -447,8 k € | -5.6% | -423,8 k € | |
| EBITDA | -634,6 k € | -150.7% | 1,3 M € | -14.5% | 1,5 M € | +46.1% | 1,0 M € | +2091.1% | 45,8 k € | +112.6% | -362,4 k € | +15.8% | -430,5 k € | -472.6% | -75,2 k € | +86.9% | -574,7 k € | +33.5% | -864,9 k € | -20.9% | -715,5 k € | |
| Operating profit | -717,1 k € | -160.8% | 1,2 M € | -14.6% | 1,4 M € | +47.2% | 938,9 k € | +58367.4% | -1,6 k € | +99.6% | -426,8 k € | +10.4% | -476,3 k € | -266.9% | -129,8 k € | +79.1% | -620,7 k € | +33.7% | -936,9 k € | -15.4% | -811,9 k € | |
| Profit/loss | -525,1 k € | -141.8% | 1,3 M € | -9.3% | 1,4 M € | +47.5% | 938,6 k € | +7510.1% | -12,7 k € | +97.1% | -438,1 k € | +10.7% | -490,4 k € | -244.4% | -142,4 k € | +77.7% | -637,3 k € | +32.1% | -937,9 k € | -15.0% | -815,7 k € | |
| Equity | 4,6 M € | -10.3% | 5,1 M € | +32.5% | 3,9 M € | +90.2% | 2,0 M € | +105.5% | 989,5 k € | +216.6% | 312,5 k € | -6.9% | 335,7 k € | -20.1% | 419,9 k € | +481.0% | 72,3 k € | -89.8% | 709,6 k € | +3.7% | 684,3 k € | |
| Total assets | 5,9 M € | +0.5% | 5,8 M € | +23.8% | 4,7 M € | +55.7% | 3,0 M € | +120.7% | 1,4 M € | +90.5% | 720,1 k € | -1.1% | 728,1 k € | -12.4% | 831,3 k € | +16.0% | 716,9 k € | -13.6% | 830,0 k € | -14.7% | 973,1 k € | |
| Cash | 414,2 k € | +6.5% | 389,0 k € | -5.5% | 411,7 k € | -72.1% | 1,5 M € | +189.8% | 509,1 k € | +93.3% | 263,4 k € | +40.1% | 188,0 k € | -57.0% | 436,8 k € | +82.3% | 239,7 k € | +244.8% | 69,5 k € | -57.9% | 165,0 k € | |
| Debts | 1,1 M € | +62.0% | 695,4 k € | -11.7% | 787,9 k € | +37.8% | 571,9 k € | +52.0% | 376,3 k € | -6.2% | 401,3 k € | +4.3% | 384,7 k € | -5.7% | 408,1 k € | -35.4% | 631,3 k € | +424.0% | 120,5 k € | -57.7% | 284,9 k € | |
| Staff | 16,5 | 15,7 | 14,7 | 14,5 | 8,1 | 6,8 | 6,8 | 5,2 | 4,6 | 5,2 | 4,8 | |||||||||||
Public limited company · Gent · incorporated on 16/09/2011 · 16,5 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+6.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ADx NeuroSciences is a Public limited company incorporated in 2011. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 16,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette